Published: 2019-09-25

Evaluate the differences in serum magnesium levels and lipid profile with correlation of hemoglobin A1C levels in type 2 diabetes patients: a case control study

B.B. Gupta, S.A. Vaidya, Mahak Bhandari, Simran Behl, Susmit Kosta


Background: Magnesium deficiency is a common problem in diabetic patients. Magnesium deficiency may increase the incidence of Type 2 Diabetic (T2D) and occurrence complications. Objective of this study aimed at determining the differences in serum magnesium levels and lipid profile among patients newly diagnosed with T2D and normoglycemic individuals.

Methods: The cross sectional observation study design was conducted at Sri Aurobindo Medical College, from March 2018 to April 2019. Source populations were all patients who attending to the OPD, Department of General Medicine. A total of 75 patients were enrolled in this study. This study was divided in two group’s cases group (T2D) and second control group (Non-diabetic). First group not initiated on any oral-hypoglycaemic, anti-hypertensive or lipid lowering drugs, and healthy patients were included in control group.

Results: Triglycerides (TG), Total Cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C) showed significantly (p<0.001) higher mean levels in T2D compared to the controls. The Magnesium and High-Density Lipoproteins-cholesterol (HDL-C) levels were significantly (p<0.001) lower among the T2D group compared to the control group. There was a significant inverse correlation (r2= 0.567, p<0.001) between Hemoglobin A1C (HbA1c) levels and serum magnesium.

Conclusions: Serum magnesium levels and lipid profile were significantly different in T2D patients compared to control group.


Hemoglobin A1C, Lipid profile, Serum magnesium, Type 2 diabetes

Full Text:



Wälti MK, Spinas GA, Hurrell RF. Low plasma magnesium in type 2 diabetes. Swiss medical weekly. 2003 May 17;133(1920).

Chehade JM, Gladysz M, Mooradian AD. Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management. Drugs. 2013; 73(4):327-39.

Institute of Medicine. Food and Nutrition Board. Dietary reference intakes: Calcium, phosphorus, magnesium, vitamin D and fluoride. National Academy Press. Washington DC, 1997.

Sales CH, Pedrosa L de F. Magnesium and diabetes mellitus: their relation. Clinical Nutrition. 2006; 25(4):554-62.

Barbagallo M, Dominguez LJ. Magnesium and type 2 diabetes World J Diab. 2015; 6(10):1152-7.

J.M. Harvey and D.G. Beevers, “Biochemical investigation of hypertension,” Annals of Clin Biochemist. 27(4):287-96.

Hua H, Gonzales J, Rude RK. Magnesium transport induced ex vivo by a pharmacological dose of insulin is impaired in non-insulin-dependent diabetes mellitus. Magnes Res. 1995;8(4):359-66.

Karim R, Nargis W, Begum KA, Subhan SS, Uddin MN. Serum lipid profile, serum magnesium and fasting serum glucose in newly diagnosed type 2 diabetic subjects. Bangladesh J Med Biochem 2014; 11;7(1):4-8.

Bal SS, Khurana D, Sharma A, Lal V, Bhansali A, Prabhakar S. Association of metabolic syndrome with carotid atherosclerosis in the young North Indian population. Diabetes Metab Syndr. 2011; 1;5(3):153-7.

Adiels M, Olofsson SO, Taskinen MR, Boren J. Overproduction of very low-density lipoproteins is the hallmark of the dsylipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008; 1;28(7):1225-36.

Sendhav SS, Kakaiya A, Chatterjee B. Evaluation of serum magnesium level along with lipid profile in a Gujarati Population diagnosed with Diabetes Mellitus. Indian J Med Biochem. 2017;21(2):112-6.

Nasri H. Lipids in association with serum magnesium in diabetes mellitus patients. Acta Angiol. 2006;12(4):149-54.